In vitro three-dimensional cell cultures for bone sarcomas

Bone sarcomas are rare tumour entities that arise from the mesenchyme most of which are highly heterogeneous at the cellular, genetic and epigenetic levels. The three main types are osteosarcoma, Ewing sarcoma, and chondrosarcoma. These oncological entities are characterised by high morbidity and mortality and an absence of significant therapeutic improvement in the last four decades. In the field of oncology, in vitro cultures of cancer cells have been extensively used for drug screening unfortunately with limited success. Indeed, despite the massive knowledge acquired from conventional 2D culture methods, scientific community has been challenged by the loss of efficacy of drugs when moved to clinical trials. The recent explosion of new 3D culture methods is paving the way to more relevant in vitro models mimicking the in vivo tumour environment (e.g. bone structure) with biological responses close to the in vivo context. The present review gives a brief overview of the latest advances of the 3D culture methods used for studying primary bone sarcomas.

Keywords: 3D culture; Bioprinting; Chondrosarcoma; Ewing sarcoma; Extracellular matrix; Microfluidics; Multicellular tumour spheroid; Osteosarcoma; Scaffold-based 3D culture.

Read the full article

Poster publication during ESB 2026 in Antwerp
Poster publication during ESB 2026 in Antwerp 09.2026
𝐋𝐨𝐧𝐠-𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧𝐬 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐛𝐞𝐬𝐭 𝐢𝐥𝐥𝐮𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐫𝐮𝐬𝐭 𝐢𝐧 𝐬𝐜𝐢𝐞𝐧𝐜𝐞 🤝 We were so pleased to meet our
Bone of the Month n°8 – The Tibia
Bone of the Month n°8 – The Tibia 08.2026
🦴 𝐁𝐨𝐧𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐌𝐨𝐧𝐭𝐡 – 8: 𝐓𝐡𝐞 Tibia 🦴 Exploring the fascinating world of bone biology… This month,
Management of donors variability in in vitro tests
Management of donors variability in in vitro tests 08.2026
🩸 Every donor is unique. From experimental design to data interpretation, we help our partners build more robust
HER2 IHC for In-Depth Cancer Characterization
HER2 IHC for In-Depth Cancer Characterization 08.2026
🧬 HER2: a key biomarker in oncology research Human Epidermal Growth Factor Receptor 2 (HER2) is one of the